Related Experiment Video
Updated: Dec 20, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Apelin-13 attenuates high glucose-induced calcification of MOVAS cells by regulating MAPKs and PI3K/AKT pathways and
Pu Zhang1, Ai-Ping Wang2, Hong-Peng Yang2
1Department of Cardiovascular Medicine, Taian City Central Hospital, Taian, Shandong, 271000, China; College of Veterinary Medicine, Shandong Agricultural University, Taian, Shandong 271018, China.
Abstract:
Vascular calcification (VC) is an inducement of many cardiovascular diseases. Clinic evidences have confirmed that diabetes was the independent risk factor for VC, and the mechanism has not been well explored. Apelin as a ligand molecule is widely found in the cardiovascular system and showed potential in inhibiting VC, but the inhibitory effect and mechanism of apelin-13 against high glucose-induced VC have not been investigated yet. Herein, apelin-13 was employed to inhibit high glucose-induced VC in mouse aortic vascular smooth muscle cells (MOVAS), and the underlying mechanism was explored. The results showed that apelin-13 significantly inhibited high glucose-induced cells proliferation, migration and invasion of MOVAS cells. Apelin-13 also effectively attenuated high glucose-induced calcification by inhibiting alkaline phosphatase (ALP) activity and expression. Further investigation revealed that apelin-13 dramatically suppressed high glucose-induced DNA damage through inhibiting reactive oxide species (ROS) generation. Moreover, apelin-13 also effectively improved high glucose-induced dysfunction of MAPKs and PI3K/AKT. Inhibition of ERK by inhibitor (U0126) significantly blocked high glucose-induced calcification, which further confirmed the significance of MAPKs. Taken together, these results suggested that apelin-13 had the potential to attenuate high glucose-induced calcification of MOVAS cells by inhibiting ROS-mediated DNA damage and regulating MAPKs and PI3K/AKT pathways. Our findings validated the strategy of using apelin-13 maybe a novel way in treating high glucose-mediated VC.
Insights
Apelin-13 peptide effectively inhibits high glucose-induced vascular calcification in mouse cells. It works by reducing DNA damage and regulating key signaling pathways, offering a potential new treatment for diabetes-related cardiovascular disease.
Area of Science:
- Cardiovascular Biology
- Cellular and Molecular Medicine
- Endocrinology
Background:
- Vascular calcification (VC) is a significant risk factor for cardiovascular diseases, often exacerbated by diabetes.
- The precise mechanisms underlying diabetes-induced VC remain incompletely understood.
- Apelin, a peptide hormone in the cardiovascular system, shows promise in inhibiting VC, but its specific role in high glucose conditions requires investigation.
Purpose of the Study:
- To investigate the inhibitory effect of apelin-13 on high glucose-induced vascular calcification (VC) in mouse aortic vascular smooth muscle cells (MOVAS).
- To explore the underlying molecular mechanisms by which apelin-13 exerts its protective effects against high glucose-induced VC.
Main Methods:
- MOVAS cells were treated with high glucose and apelin-13.
- Cell proliferation, migration, invasion, and alkaline phosphatase (ALP) activity/expression were assessed.
- Reactive oxygen species (ROS) generation, DNA damage, and the activation of MAPKs and PI3K/AKT pathways were analyzed.
- The role of MAPKs was further confirmed using the ERK inhibitor U0126.
Main Results:
- Apelin-13 significantly inhibited high glucose-induced proliferation, migration, and invasion of MOVAS cells.
- Apelin-13 attenuated high glucose-induced calcification by reducing ALP activity and expression.
- Apelin-13 suppressed high glucose-induced DNA damage by inhibiting ROS generation.
- Apelin-13 improved high glucose-induced dysfunction in MAPKs and PI3K/AKT signaling pathways.
- Inhibition of ERK signaling blocked high glucose-induced calcification, highlighting the role of MAPKs.
Conclusions:
- Apelin-13 demonstrates significant potential in attenuating high glucose-induced vascular calcification in MOVAS cells.
- The mechanism involves the inhibition of ROS-mediated DNA damage and the regulation of MAPKs and PI3K/AKT pathways.
- Apelin-13 represents a promising therapeutic strategy for managing high glucose-mediated vascular calcification.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
07:36Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
The Intrinsic Apoptotic Pathway